Does Eric Rabinowitz’s Hire Sharpen Evercore’s (EVR) Edge in Healthcare Advisory or Signal a Broader Shift?

Simply Wall St.07-08 20:30

Evercore recently announced that Eric Rabinowitz has joined the firm as a senior managing director in its healthcare investment banking group in New York, bringing more than 20 years of sector-focused...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2649871999?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/7132000-choice1-main-header/1585186724276","is_english":true,"pubTime":"2026-07-08 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649871999","market":"hk","top_or_hot":-1,"title":"Does Eric Rabinowitz’s Hire Sharpen Evercore’s (EVR) Edge in Healthcare Advisory or Signal a Broader Shift?","media":"Simply Wall St.","content":"<div>\n<p>Evercore recently announced that Eric Rabinowitz has joined the firm as a senior managing director in its healthcare investment banking group in New York, bringing more than 20 years of sector-focused...</p>\n\n<a href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-evr/evercore/news/does-eric-rabinowitzs-hire-sharpen-evercores-evr-edge-in-hea\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Does Eric Rabinowitz’s Hire Sharpen Evercore’s (EVR) Edge in Healthcare Advisory or Signal a Broader Shift?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoes Eric Rabinowitz’s Hire Sharpen Evercore’s (EVR) Edge in Healthcare Advisory or Signal a Broader Shift?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-08 20:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/diversified-financials/nyse-evr/evercore/news/does-eric-rabinowitzs-hire-sharpen-evercores-evr-edge-in-hea><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Evercore recently announced that Eric Rabinowitz has joined the firm as a senior managing director in its healthcare investment banking group in New York, bringing more than 20 years of sector-focused...</p>\n\n<a href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-evr/evercore/news/does-eric-rabinowitzs-hire-sharpen-evercores-evr-edge-in-hea\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0029874061.USD","symbol_name":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nyse-evr/evercore/news/does-eric-rabinowitzs-hire-sharpen-evercores-evr-edge-in-hea","article_id":"2649871999","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/7132000-choice1-main-header/1585186724276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nyse-evr/evercore/news/does-eric-rabinowitzs-hire-sharpen-evercores-evr-edge-in-hea","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2649871999","pubTimestamp":1783513804,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Evercore recently announced that Eric Rabinowitz has joined the firm as a senior managing director in its healthcare investment banking group in New York, bringing more than 20 years of sector-focused deal-making and corporate development experience from J.P. Morgan, Perrigo, Barclays and other major institutions.\nHis appointment adds a seasoned healthcare M&A specialist with deep client relationships to Evercore’s advisory platform, potentially reinforcing the firm’s sector coverage at a...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","EVR.AU":"EV Resources Ltd","BK4585":"ETF&股票定投概念","LABU":"三倍做多标普生物-Direxion","XLV":"健康照护类股ETF-SPDR","BK4127":"投资银行业与经纪业","BK4588":"碎股","EVR":"Evercore","BK7095":"多种金属与采矿","BK4137":"综合支持服务","BK4581":"高盛持仓","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","XBI":"SPDR S&P Biotech ETF","BK7504":"锂钴概念","HCSG":"Healthcare Svcs Group Inc"},"translate_title":"埃里克·拉宾诺维茨(Eric Rabinowitz)的聘用是否会增强Evercore(EVR)在医疗保健咨询领域的优势，还是预示着更广泛的转变？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVR":1.5,"LABU":0.6,"XBI":0.6,"XLV":1.5,"HCSG":1.5,"EVR.AU":1.5},"content_text":"Evercore recently announced that Eric Rabinowitz has joined the firm as a senior managing director in its healthcare investment banking group in New York, bringing more than 20 years of sector-focused deal-making and corporate development experience from J.P. Morgan, Perrigo, Barclays and other major institutions. His appointment adds a seasoned healthcare M&A specialist with deep client relationships to Evercore’s advisory platform, potentially reinforcing the firm’s sector coverage at a time when it has been investing heavily in specialist talent and global expansion. We’ll now consider how the addition of a seasoned healthcare M&A leader like Rabinowitz may influence Evercore’s longer-term investment narrative. We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.AdvertisementEvercore Investment Narrative RecapTo own Evercore, you generally have to believe its independent advisory model and sector depth can keep attracting high-fee mandates, even as costs and competition stay elevated. The Rabinowitz hire fits this story by bolstering healthcare M&A coverage, but it does not materially change the near term tension between rising fixed expenses and reliance on cyclical deal activity, which remains a key risk if transaction volumes soften. The most directly relevant recent announcement is Evercore’s broader hiring spree of senior dealmakers and product specialists across healthcare, private capital advisory and sector teams in New York and Europe. Together with Rabinowitz’s arrival, this pattern underlines a clear focus on deepening capabilities in fee rich verticals, which could support the existing catalysts around advisory revenue growth while also amplifying the risk that compensation and non-compensation costs stay high if activity slows. Yet behind this hiring momentum, investors should still pay close attention to how exposed Evercore remains to a potential stretch of weaker M&A volumes and... Read the full narrative on Evercore (it's free!)Evercore’s narrative projects $5.2 billion in revenue and $768.8 million in earnings by 2029.Uncover how Evercore's forecasts yield a $374.60 fair value, a 8% upside to its current price.Exploring Other PerspectivesEVR 1-Year Stock Price Chart Some of the most optimistic analysts were already penciling in about US$6.6 billion of revenue and US$1.0 billion of earnings by 2029, so if you see Rabinowitz’s hire as easing long term talent risk, you may view their narrative as less aggressive, while others might still worry that so much depends on senior bankers staying put.Explore 3 other fair value estimates on Evercore - why the stock might be worth as much as 25% more than the current price!Decide For YourselfDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Evercore research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.Our free Evercore research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Evercore's overall financial health at a glance.Interested In Other Possibilities?These stocks are moving-our analysis flagged them today. Act fast before the price catches up:Outshine the giants: these 15 early-stage AI stocks could fund your retirement.Find 45 companies with promising cash flow potential yet trading below their fair value.Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Evercore might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2649871999","isCrawlerRequest":true}